What Is Drug Delivery?

Drug delivery is the field concerned with the methods, technologies, and materials used to transport therapeutic compounds to their intended sites of action within the body, with the goal of maximising efficacy while limiting side effects. It spans the design of dosage forms, carrier systems, and devices that control the rate, location, and timing at which an active pharmaceutical ingredient reaches target tissues or cells. The discipline sits at the intersection of biomedical engineering, materials science, pharmacology, and chemical engineering, and it informs both conventional oral and injectable formulations and advanced implantable or electronically controlled devices.

Traditional drug delivery through tablets or intravenous infusion exposes the entire body to a therapeutic agent, which can create toxicity at off-target tissues and requires repeated dosing as plasma concentrations fluctuate. Controlled and targeted delivery addresses these limitations by engineering the release profile to maintain drug concentration within a therapeutic window for extended periods and by directing the agent to diseased tissue, reducing the required dose and systemic exposure.

Nanocarriers and Particulate Systems

Nanocarriers are submicron-scale structures, typically 10 to 500 nanometres in diameter, engineered to encapsulate, protect, and transport drug molecules. Common nanocarrier platforms include liposomes (lipid bilayer vesicles), polymeric nanoparticles, dendrimers, solid lipid nanoparticles, and inorganic nanostructures such as mesoporous silica. Surface modification with polyethylene glycol (PEG) extends circulation time by reducing uptake by the mononuclear phagocyte system; attachment of targeting ligands such as antibodies or aptamers directs the carrier to receptors overexpressed on tumour cells or inflamed tissue. The National Institutes of Health review of advances in nanoparticle drug delivery provides foundational context on how the pharmacokinetic behaviour of small molecules changes when they are encapsulated in particulate carriers.

Controlled Release and Targeted Delivery

Controlled release systems are formulated or fabricated to maintain drug concentration within the therapeutic range for hours to months after a single administration, as opposed to the sharp peak and rapid decline typical of a bolus dose. Polymer matrices, hydrogels, and osmotic pumps achieve zero-order or first-order release kinetics by governing how quickly water diffuses into the system and drug diffuses out. Stimuli-responsive systems release their payload only when triggered by a local biochemical signal such as pH, enzyme activity, or temperature, enabling tumour-specific or infection-specific delivery. The engineering of implantable drug delivery systems, including the challenges of biocompatibility and long-term device performance, is reviewed in Lab on a Chip research on active implantable drug delivery systems, which covers actuation mechanisms from electrolytic pumps to shape-memory polymers.

Implantable and Wearable Delivery Devices

Implantable devices represent a subset of drug delivery systems in which a depot or active pump is surgically placed within the body to release drug over weeks or years. Cochlear drug delivery, intraocular implants for retinal diseases, and intrathecal pumps for chronic pain management are established clinical examples. Wirelessly controlled implantable systems add a programmable dimension, allowing clinicians or patients to adjust release rates remotely via an inductively coupled link or Bluetooth interface. Wearable patch-based delivery systems use iontophoresis or microneedle arrays to transport macromolecules through the skin without injection, with emerging applications in continuous hormone delivery and wearable diagnostics. The integration of wireless control into implantable systems is covered in Nature Reviews Electrical Engineering on wirelessly controlled drug delivery, which surveys actuation, power telemetry, and closed-loop feedback approaches.

Applications

Drug delivery has applications in a wide range of fields, including:

• Oncology, where nanocarrier-based chemotherapy reduces systemic toxicity compared to free drug infusion
• Chronic disease management, through sustained-release oral formulations and implantable insulin pumps for diabetes
• Infectious disease treatment, using antibiotic-loaded implants and wound dressings that release antimicrobials locally
• Ophthalmology, with intravitreal implants that maintain therapeutic drug levels in the eye for months
• Gene and RNA therapy, where lipid nanoparticles deliver nucleic acid payloads to target cells